Food Webs in the Human Body: Linking Ecological Theory to Viral Dynamics

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Murall, Carmen Lía ^a   McCann, Kevin S ^a   Bauch, Chris T ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABIOTIC STRESS; ARTICLE; CROSS REACTION; ECOLOGY; ENVIRONMENTAL CHANGE; EVOLUTIONARY ADAPTATION; FOOD WEB; HOST PATHOGEN INTERACTION; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION CONTROL; LIFE HISTORY TRAIT; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PAPILLOMAVIRUS INFECTION; PREDATOR PREY INTERACTION; SMOKING HABIT; VACCINATION; VIRUS LOAD; VIRUS STRAIN; VIRUS VIRULENCE; WEIGHT GAIN;

ECOLOGY; FOOD CHAIN; HOST-PARASITE INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 84869105137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048812     Document Type: Article

References (60)

1. Williams PD, Day T, (2008) Epidemiological and evolutionary consequences of targeted vaccination. Molecular ecology 17: 485-499 doi:10.1111/j.1365-294X.2007.03418.x.
2. Andersson DI, Hughes D, (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nature reviews Microbiology 8: 260-271 doi:10.1038/nrmicro2319.
3. Gandon S, Mackinnon M, Nee S, Read A, (2003) Imperfect vaccination: some epidemiological and evolutionary consequences. Proceedings of the Royal Society B: Biological Sciences 270: 1129-1136 doi:10.1098/rspb.2003.2370.
4. Nair V, (2005) Evolution of Marek's disease - a paradigm for incessant race between the pathogen and the host. Veterinary journal 170: 175-183 doi:10.1016/j.tvjl.2004.05.009.
5. Greenberg D, (2009) The Shifting Dynamics of Pneumococcal Invasive Disease after the Introduction of the Pneumococcal 7-Valent Conjugated Vaccine?: Toward the New Pneumococcal Conjugated Vaccines. Clinical Infectious Diseases 49: 213-215.
6. Perelson AS, (2002) Modelling viral and immune system dynamics. Nature reviews Immunology 2: 28-36 doi:10.1038/nri700.
7. Beauchemin CAA, McSharry JJ, Drusano GL, Nguyen JT, Went GT, et al. (2008) Modeling amantadine treatment of influenza A virus in vitro. Journal of theoretical biology 254: 439-451 doi:10.1016/j.jtbi.2008.05.031.
8. Gilchrist MA, Coombs D, (2006) Evolution of virulence: interdependence, constraints, and selection using nested models. Theoretical population biology 69: 145-153 doi:10.1016/j.tpb.2005.07.002.
9. Day T, Galvani A, Struchiner C, Gumel A, (2008) The evolutionary consequences of vaccination. Vaccine 26: C1-C3 doi:10.1016/j.vaccine.2008.02.006.
10. Mideo N, Barclay VC, Chan BHK, Savill NJ, Read AF, et al. (2008) Understanding and predicting strain-specific patterns of pathogenesis in the rodent malaria Plasmodium chabaudi. The American naturalist 172: 214-238 doi:10.1086/591684.
11. Levin B, (2001) How can we predict the ecologic impact of an antimicrobial: the opinions of a population and evolutionary biologist. Clinical Microbiology and Infection 7: 24-28.
12. Dennehy JJ, Friedenberg N a, Holt RD, Turner PE, (2006) Viral ecology and the maintenance of novel host use. The American Naturalist 167: 429-439.
13. Nowak MA, May RM (2000) Viral Dynamics: mathematical principles of immunology and virology. Oxford University Press. p.
14. Alizon S, Hurford A, Mideo N, Van Baalen M, (2009) Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. Journal of evolutionary biology 22: 245-259 doi:10.1111/j.1420-9101.2008.01658.x.
15. Frank SA (2002) Immunology and Evolution of Infectious Diseases. NJ: Princeton University Press. p.
16. Pedersen AB, Fenton A, (2007) Emphasizing the ecology in parasite community ecology. Trends in ecology & evolution 22: 133-139 doi:10.1016/j.tree.2006.11.005.
17. Fenton A, Perkins SE, (2010) Applying predator-prey theory to modelling immune-mediated, within-host interspecific parasite interactions. Parasitology 137: 1027-1038 doi:10.1017/S0031182009991788.
18. Smith VH, Holt RD, (1996) Resource competition and within-host disease dynamics. Trends in ecology & evolution 11: 386-389.
19. Holt RD (1997) Community modules. In: Brown CG& VK, editor. Multitrophic interactions in terrestrial ecosystems, 36th Symposium of the British Ecological Society. London, UK: Blackwell Science Ltd. Ives.
20. Holt RD, (1977) Predation, apparent competition, and the structure of prey communities. Theoretical Population Biology 12: 197-229.
21. Mideo N, (2009) Parasite adaptations to within-host competition. Trends in parasitology 25: 261-268 doi:10.1016/j.pt.2009.03.001.
22. Wootton JT, Emmerson M, (2005) Measurement of Interaction Strength in Nature. Annual Review of Ecology, Evolution and Systematics 36: 419-444 doi:10.1146/annurev.ecolsys.36.091704.175535.
23. De Paepe M, Taddei F, (2006) Viruses' life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages. PLoS Biology 4: e193 doi:10.1371/journal.pbio.0040193.
24. Bender E, Case T, Gilpin M, (1984) Perturbation experiments in community ecology: theory and practice. Ecology 65: 1-13.
25. O'Gorman EJ, Emmerson MC, (2009) Perturbations to trophic interactions and the stability of complex food webs. Proceedings of the National Academy of Sciences of the United States of America 106: 13393-13398 doi:10.1073/pnas.0903682106.
26. Colijn C, Cohen T, Fraser C, Hanage W, Goldstein E, et al. (2010) What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? Journal of the Royal Society, Interface 7: 905-919 doi:10.1098/rsif.2009.0400.
27. Christensen N, Bounds C, (2010) Cross-protective responses to human papillomavirus infection. Future Virology 5: 163.
28. Booth M, Graham A, (2008) Parasitic co-infections: challenges and solutions. Parasitology 135: 749 doi:10.1017/S0031182008000413.
29. Tilman D (1982) Resource competition and community structure. Volume 17. Princeton University Press. p.
30. Simen-Kapeu A, Kataja V, Yliskoski M, Syrjänen K, Dillner J, et al. (2008) Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scandinavian Journal of Infectious Diseases 40: 745-751.
31. Luchters SMF, Vanden Broeck D, Chersich MF, Nel A, Delva W, et al. (2010) Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC infectious diseases 10: 18 doi:10.1186/1471-2334-10-18.
32. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA 3rd (2010) Women with HIV are more commonly infected with non-16 and-18 high-risk HPV types. Gynecologic oncology 116: 572-577 doi:10.1016/j.ygyno.2009.10.058.
33. Lafferty KD, Allesina S, Arim M, Briggs CJ, De Leo G, et al. (2008) Parasites in food webs: the ultimate missing links. Ecology letters 11: 533-546 doi:10.1111/j.1461-0248.2008.01174.x.
34. Grenfell B, Harwood J, (1997) (Meta) population dynamics of infectious diseases. Trends in Ecology & Evolution 12: 395-399.
35. Mideo N, Alizon S, Day T, (2008) Linking within- and between-host dynamics in the evolutionary epidemiology of infectious diseases. Trends in ecology & evolution 23: 511-517 doi:10.1016/j.tree.2008.05.009.
36. Merikukka M, Kaasila M, Namujju PB, Palmroth J, Kirnbauer R, et al. (2011) Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. International journal of cancer 128: 1114-1119 doi:10.1002/ijc.25675.
37. Tota J, Agnihotram RV, Coutlée F, Villa LL, Richardson H, et al. (2011) Epidemiologic approach to evaluate potential for HPV type replacement post-vaccination: O-01.04.
38. García-Vallvé S, Alonso A, Bravo IG, (2005) Papillomaviruses: different genes have different histories. Trends in microbiology 13: 514-521 doi:10.1016/j.tim.2005.09.003.
39. Doorbar J, (2005) The papillomavirus life cycle. Journal of clinical virology 32Suppl 1: S7-15 doi:10.1016/j.jcv.2004.12.006.
40. Bauer AL, Beauchemin C a a, Perelson AS, (2009) Agent-based modeling of host-pathogen systems: The successes and challenges. Information Sciences 179: 1379-1389 doi:10.1016/j.ins.2008.11.012.
41. Funk GA, Jansen VA, Bonhoeffer S, Killingback T, (2005) Spatial models of virus-immune dynamics. Journal of theoretical biology 233: 221-236 doi:10.1016/j.jtbi.2004.10.004.
42. Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez AC, et al. (2011) Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. The Journal of infectious diseases 204: 385-390 doi:10.1093/infdis/jir286.
43. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, et al. (2012) One virus, one lesion-individual components of CIN lesions contain a specific HPV type. The Journal of pathology 227: 62-71 doi:10.1002/path.3970.
44. Wodarz D, Levy DN (2009) Multiple HIV-1 infection of cells and the evolutionary dynamics of Cytotoxic T Lymphocyte escape mutants. Evolution: 2326-2339. doi:10.1111/j.1558-5646.2009.00727.x.
45. Polis G, Myers C, Holt R, (1989) The ecology and evolution of intraguild predation: potential competitors that eat each other. Annual Review of Ecology and Systematics 20: 297-330.
46. Antia R, Bergstrom CT, Pilyugin SS, Kaech SM, (2003) Models of CD8+ Responses: 1. What is the Antigen-independent Proliferation Program. Journal of Theoretical Biology 221: 585-598.
47. Nowak M, Bangham CRM, (1996) Population dynamics of immune responses to persistent viruses. Science 272: 74-79.
48. Liang H, Miao H, Wu H, (2010) Estimation of Constant and Time-Varying Dynamic Parameters of Hiv Infection in a Nonlinear Differential Equation Model. The annals of applied statistics 4: 460-483.
49. Wang H-K, Duffy AA, Broker TR, Chow LT, (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes & Development 23: 181-194.
50. Stanely MA (2006) Immunobiology of Papillomaviruses. In: Campo MS, editor. Papillomavirus Research: from natural history to vaccines and beyond. Horizon Scientific Press. p. 311.
51. Culp TD, Christensen ND, (2004) Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 319: 152-161 doi:10.1016/j.virol.2003.11.004.
52. Frattini MG, Lim HB, Laimins LA, (1996) In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. PNAS 93: 3062-3067.
53. Althaus CL, De Boer RJ, (2011) Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection. PloS ONE 6: e16468 doi:10.1371/journal.pone.0016468.g002.
54. Adams BM, Banks HT, Davidian M, Kwon H-D, Tran HT, et al. (2005) HIV dynamics: Modeling, data analysis, and optimal treatment protocols. Journal of Computational and Applied Mathematics 184: 10-49 doi:10.1016/j.cam.2005.02.004.
55. de Boer R, Oprea M, Antia R, Murali-krishna K, Ahmed R, et al. (2001) Recruitment times, proliferation, and apoptosis rates during the CD8+ T-cell response to lymphocytic choriomeningitis virus. Journal of Virology 35: 10663-10669 doi:10.1128/JVI.75.22.10663-10669.2001.
56. Ribeiro RM, Mohri H, Ho DD, Perelson AS, (2002) In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? PNAS 99: 15572-15577 doi:10.1073/pnas.242358099.
57. Stämpfli MR, Anderson GP, (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nature reviews Immunology 9: 377-384.
58. Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, et al. (2009) Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer epidemiology, biomarkers & prevention 18: 3490-3496.
59. Nadais RDF, Campaner AB, Piato S, Longo Galvão MA, dos Santos RE, et al. (2006) Langerhans' cells and smoking in intraepithelial neoplasia of the cervix. Gynecologic oncology 102: 356-360 doi:10.1016/j.ygyno.2005.12.030.
60. Schiller JT, Castellsagué X, Villa LL, Hildesheim A, (2008) An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 26Suppl 1: K53-61 doi:10.1016/j.vaccine.2008.06.002.